Related Experiment Video
Updated: Jul 24, 2025

11:06
Human Liver Microphysiological System for Assessing Drug-Induced Liver Toxicity In Vitro
Published on: January 31, 2022
4.5K
The Accuracy of Nonstandardized MELD/PELD Score Exceptions in the Pediatric Liver Allocation System
Daniel J Ahn1, Sharon Zeng2, Kenley M Pelzer3
1Department of Surgery, Stanford University, Stanford, CA.
Transplantation
|July 6, 2023
Summary
Pediatric liver transplant candidates receiving score exceptions face higher mortality risk. These exceptions, particularly "nonstandardized" ones, inaccurately reflect true pretransplant mortality risk in end-stage liver disease (ESLD) patients.
Area of Science:
- Hepatology
- Transplant Surgery
- Pediatric Gastroenterology
Background:
- Over half of pediatric liver transplant candidates in the U.S. receive score exceptions.
- These exceptions increase priority on the waitlist, potentially above their actual mortality risk.
- The accuracy of these "nonstandardized" exceptions in reflecting true pretransplant mortality risk is questioned.
Purpose of the Study:
- To determine if MELD/PELD exceptions accurately reflect pretransplant mortality risk in pediatric liver failure patients.
- To compare the predictive accuracy of laboratory MELD/PELD scores versus allocation MELD/PELD scores with exceptions.
- To assess the impact of the National Liver Review Board on exception rates.
Main Methods:
- Analysis of Scientific Registry of Transplant Recipients data for pediatric candidates (<18 years) with chronic liver failure.
- Use of mixed-effects Cox proportional hazards models to estimate pretransplant mortality.
- Comparison of laboratory MELD/PELD and allocation MELD/PELD performance using concordance statistics.
Main Results:
- Candidates prioritized by laboratory MELD/PELD had a significantly higher mortality risk (HR 8.69) than those with exception-based scores.
- Laboratory MELD/PELD scores were more accurate predictors of mortality (c-index 0.843) than allocation MELD/PELD scores (c-index 0.763).
- The proportion of patients with active exceptions decreased significantly post-National Liver Review Board implementation (67.4% vs. 43.4%).
Conclusions:
- Nonstandardized exceptions negatively impact the accurate ranking of pediatric liver failure candidates.
- Current exception policies may not adequately represent true pretransplant mortality risk.
- The National Liver Review Board has reduced the prevalence of active exceptions at transplant.

